Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rituximab for tumefactive inflammatory demyelination: a case report.

Rituximab for tumefactive inflammatory demyelination: a case report. Clin Neurol Neurosurg. 2012 Dec; 114(10):1326-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.